Summaries of the Section H (HML) update

Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.

The full Update will be available as a PDF on our website(external link)

The changes will be published in the online HML around the 23rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.

18 January 2022 - preview of changes for February 2022

Pharmaceutical	Change
Barcitinib (Olumiant) tab 2 mg and 4 mg	new listing tab 2 mg (p’code 2631229) tab 4 mg (p’code 2631237)
Betahistine dihydrochloride tab 16 mg	Brand change Serc – new listing and transfer of HSS (p’code 2611376) Vergo 16 – to be delisted 1 July 2022
Bortezomib inj 2.5 mg vial	presentation to be delisted 1 August 2022
Calcium lactate gluconate with calcium carbonate (e.g. Calcium-Sandoz Forte) tab eff 2.94 g with calcium carbonate 0.3 g (500 mg elemental)	chemical name change
Casirivimab and imdevimab (Ronapreve) inj 120 mg per ml casirivimab, 11.1 ml vial (1) and inj 120 mg per ml imdevimab, 11.1 ml vial (1), 1 treatment pack	new listing (p’code 2630923)
Clonidine hydrochloride (Clonidine Teva) tab 25 mcg	new listing (p’code 2630249)
Megestrol acetate (Megace) tab 160 mg	new listing and to be delisted 1 February 2023 (p’code 2630966)
Mivacurium chloride (Mivacron) inj 2 mg per ml, 5 ml ampoule	brand to be delisted 1 August 2022
Mivacurium chloride (Mivacron) inj 2 mg per ml, 10 ml ampoule	brand delisted 1 February 2022
Oxycodone hydrochloride inj 10 mg per ml, 1 ml and 2 ml ampoule inj 50 mg per ml, 1 ml ampoule	Brand change Hameln– new listing and addition of PSS inj 10 mg per ml, 1 ml ampoule (p’code 2631172) inj 10 mg per ml, 2 ml ampoule (p’code 2631180) inj 50 mg per ml, 1 ml ampoule (p’code 2631199) Oxynorm – to be delisted 1 July 2022
Oxazepam (Ox-Pam) tab 10 mg and 15 mg	brand to be delisted 1 April 2022
Nicotine oral spray 1 mg per dose (e.g. Nicorette QuickMist Mouth Spray) soln for inhalation 15 mg cartridge (e.g. Nicorette Inhalator)	amended restriction criteria
Paediatric oral feed 1 kcal/ml (Pediasure (Chocolate, Strawberry and Vanilla)) liquid 2.8 g protein, 11.2 g carbohydrate and 5 g fat per 100 ml, bottle	presentation description change
Paediatric oral feed 1 kcal/ml (Pediasure (Vanilla)) liquid 2.8 g protein, 11.2 g carbohydrate and 5 g fat per 100 ml, can, 250 ml	presentation description change
Paediatric oral feed 1.5 kcal/ml (e.g. Pediasure Plus) liquid 4.2 g, 16.7 g carbohydrate and 7.5 g fat per 100 ml, 500 ml bottle	new listing
Sunitinib cap 12.5 mg, 25 mg and 50 mg	Brand change Sunitinib Pfizer– new listing and addition of PSS cap 12.5 mg (p’code 2630303) cap 25 mg (p’code 2630311) cap 50 mg (p’code 2630338) Sutent – to be delisted 1 July 2022
Tocilizumab (Actemra) inj 20 mg per ml, 4 ml vial, 10 ml vial and 20 ml vial	amended restriction criteria

Find previous months' summaries